Top MarketRank™ StocksTop MarketRank™NYSE:CHE Chemed (CHE) Stock Price, News & Analysis $549.27 +8.30 (+1.53%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$541.53▼$553.9550-Day Range$527.55▼$565.2352-Week Range$492.84▼$654.62Volume132,672 shsAverage Volume85,684 shsMarket Capitalization$8.32 billionP/E Ratio29.56Dividend Yield0.29%Price Target$673.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Chemed alerts: Email Address Chemed MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside22.6% Upside$673.50 Price TargetShort InterestHealthy1.99% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.33Upright™ Environmental ScoreNews Sentiment0.42Based on 18 Articles This WeekInsider TradingSelling Shares$3.24 M Sold Last QuarterProj. Earnings Growth11.05%From $21.54 to $23.92 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.92 out of 5 starsMedical Sector20th out of 936 stocksHome Health Care Services Industry2nd out of 8 stocks 2.5 Analyst's Opinion Consensus RatingChemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageChemed has only been the subject of 1 research reports in the past 90 days.Read more about Chemed's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.99% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemed has recently decreased by 5.41%, indicating that investor sentiment is improving significantly. Previous Next 3.3 Dividend Strength Dividend YieldChemed has a dividend yield of 0.30%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 15 years.Dividend CoverageThe dividend payout ratio of Chemed is 8.61%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 6.69% next year. This indicates that Chemed will be able to sustain or increase its dividend.Read more about Chemed's dividend. Previous Next 4.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreChemed has received a 80.32% net impact score from Upright. Chemed seems to create the most significant positive value in categories "Taxes", "Jobs", and "Meaning & joy". The positive contribution in the "Meaning & joy" impact category is mostly driven by its "Private hospice care", "Private home care for the elderly", and "Property water damage restoration" products. See details.Environmental SustainabilityThe Environmental Impact score for Chemed is -0.33. Previous Next 2.5 News and Social Media Coverage News SentimentChemed has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Chemed this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added Chemed to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,240,053.00 in company stock.Percentage Held by InsidersOnly 3.32% of the stock of Chemed is held by insiders.Percentage Held by Institutions95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Chemed's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Chemed are expected to grow by 11.05% in the coming year, from $21.54 to $23.92 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 29.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.79.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 29.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 157.66.Price to Earnings Growth RatioChemed has a PEG Ratio of 2.25. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 7.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Chemed's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsThe next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.Click here to learn more. About Chemed Stock (NYSE:CHE)Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Read More CHE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHE Stock News HeadlinesJuly 26 at 6:48 AM | finance.yahoo.comQ2 2024 Chemed Corp Earnings CallJuly 25 at 8:43 PM | finance.yahoo.comChemed Corporation (CHE)July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 25 at 3:17 PM | seekingalpha.comChemed Corporation (CHE) Q2 2024 Earnings Call TranscriptJuly 25 at 10:15 AM | markets.businessinsider.comChemed Corp. Q2 Profit Increases, But Misses EstimatesJuly 25 at 10:15 AM | finance.yahoo.comChemed Reports Second-Quarter 2024 ResultsJuly 23, 2024 | markets.businessinsider.comChemed earnings preview: what to expectJuly 20, 2024 | finance.yahoo.comA Look At The Fair Value Of Chemed Corporation (NYSE:CHE)July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 17, 2024 | americanbankingnews.comChemed (CHE) Set to Announce Earnings on WednesdayJuly 1, 2024 | stocknews.com3 High-Profitability Healthcare Stocks to Buy for Consistent ReturnsJuly 1, 2024 | businesswire.comChemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25June 8, 2024 | gurufocus.comInsider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)May 29, 2024 | businesswire.comChemed Corporation to Present at the Jefferies 2024 Global Healthcare ConferenceMay 29, 2024 | edition.cnn.comAcadia Healthcare Company, Inc.May 24, 2024 | finance.yahoo.comChemed (CHE) Down 3.1% Since Last Earnings Report: Can It Rebound?May 21, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Hookipa Pharma (HOOK), Chemed (CHE)May 20, 2024 | seekingalpha.comChemed: Growth Does Not Justify The Current Stock PriceSee More Headlines Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 6/18 Dividend5/30/2024Dividend Payable6/18/2024Last Earnings7/24/2024Today7/26/2024Next Earnings (Estimated)10/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Home health care services Sub-IndustryHealth Care Services Current SymbolNYSE:CHE CUSIP16359R10 CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees15,087Year Founded1970Price Target and Rating Average Stock Price Target$673.50 High Stock Price Target$697.00 Low Stock Price Target$650.00 Potential Upside/Downside+22.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$18.58 Trailing P/E Ratio29.56 Forward P/E Ratio25.50 P/E Growth2.25Net Income$272.51 million Net Margins12.88% Pretax Margin15.86% Return on Equity29.90% Return on Assets19.97% Debt Debt-to-Equity RatioN/A Current Ratio1.91 Quick Ratio1.88 Sales & Book Value Annual Sales$2.34 billion Price / Sales3.56 Cash Flow$24.64 per share Price / Cash Flow22.29 Book Value$73.55 per share Price / Book7.47Miscellaneous Outstanding Shares15,139,000Free Float14,636,000Market Cap$8.32 billion OptionableOptionable Beta0.43 Social Links The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Kevin J. McNamara (Age 70)CEO, President & Director Comp: $5.84MMr. Michael D. Witzeman CPA (Age 53)MBA, VP, Controller, Principal Accounting Officer & CFO Comp: $1.15MMr. Spencer S. Lee (Age 68)Executive Vice President Comp: $1.65MMr. Thomas C. Hutton (Age 73)VP & Director Mr. Nicholas Michael Westfall (Age 45)Executive Vice President Comp: $2.5MMs. Lisa A. ReinhardVP, Chief Administrative Officer & SecretarySherri WarnerDirector of Investor RelationsMr. Brian C. Judkins (Age 43)VP, Secretary & Chief Legal Officer More ExecutivesKey CompetitorsLaboratory Co. of AmericaNYSE:LHQuest DiagnosticsNYSE:DGXDaVitaNYSE:DVAR1 RCMNASDAQ:RCMCorVelNASDAQ:CRVLView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 1,156 shares on 7/26/2024Ownership: 1.000%Allspring Global Investments Holdings LLCBought 16,518 shares on 7/26/2024Ownership: 0.115%State of Michigan Retirement SystemSold 100 shares on 7/26/2024Ownership: 0.024%Argonautica Private Wealth Management Inc.Bought 47 shares on 7/26/2024Ownership: 0.003%Eagle Bay Advisors LLCSold 19 shares on 7/26/2024Ownership: 0.001%View All Insider TransactionsView All Institutional Transactions CHE Stock Analysis - Frequently Asked Questions How have CHE shares performed this year? Chemed's stock was trading at $584.75 at the beginning of 2024. Since then, CHE shares have decreased by 6.1% and is now trading at $549.27. View the best growth stocks for 2024 here. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) posted its quarterly earnings data on Wednesday, July, 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.59 by $0.12. The business's quarterly revenue was up 7.6% compared to the same quarter last year. What is Kevin J. McNamara's approval rating as Chemed's CEO? 1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are Chemed's major shareholders? Top institutional shareholders of Chemed include Boston Trust Walden Corp (1.46%), Bank of New York Mellon Corp (1.00%), Schwartz Investment Counsel Inc. (0.78%) and Raymond James & Associates (0.48%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Nicholas Michael Westfall, Donald E Saunders, Patrick P Grace, Michael D Witzeman and Brian C Judkins. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS) and Boeing (BA). This page (NYSE:CHE) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
